Markets.com Logo

KALY

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0$
  • Previous Close
    0$
  • 52 Week Change
    0.00$
  • Day Range
    0.00$
  • 52 Week High/Low
    0$ - 0.0001$
  • Dividend Per Share
    --
  • Market cap
    815 K$
  • EPS
    2.13
  • Beta
    -91.13
  • Volume
    --

About

KALY.US refers to Kalytera Therapeutics, Inc. It's a pharmaceutical company that focuses on developing and commercializing novel cannabinoid-based therapies for various diseases, including graft-versus-host disease and inflammatory bowel disease. The .US indicates that the stock is listed on a United States stock exchange.

AMD's Share Price Surges to Record Highs Driven by Server CPU Momentum

Noah Lee|--

Gold Volatility: Is a Structural Shift Underway? An In-depth Analysis

Noah Lee|--

S&P 500's Record Rally Continues: Nomura Strategist Flags Two Key Exit Signals

Liam James|--
Crypto Market Analysis: Why Does South Korea Now Account for 30% of Global Crypto Trading Volume?

Crypto Market Analysis: Why Does South Korea Now Account for 30% of Global Crypto Trading Volume?

Ghko B|--
Forex market analysis: NZD/USD approaches 0.5900, what could influence its next moves?

Forex market analysis: NZD/USD approaches 0.5900, what could influence its next moves?

Frances Wang|--
Stock Market Analysis: How Much Will S&P 500 Strength Influence UAE Stock Recovery in 2026?

Stock Market Analysis: How Much Will S&P 500 Strength Influence UAE Stock Recovery in 2026?

Ghko B|--

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Factors

Clinical Trial Results: Positive data from clinical trials for Kalytera's drug candidates can drive stock prices up, while negative results often lead to a decrease.

Regulatory Approvals: Approvals from regulatory bodies like the FDA can significantly increase stock value, while rejections can cause it to plummet.

Market Sentiment: Overall investor optimism or pessimism towards the biotech sector or Kalytera specifically influences trading volume and stock price.

Financial Performance: Company revenues, profitability, and cash flow impact investor confidence and influence stock valuation.

Competition: The presence of competing therapies or companies in the same therapeutic area can affect Kalytera's market share and stock price.

Partnerships & Acquisitions: Strategic collaborations or potential acquisitions can boost stock prices due to increased resources and market access.

People Also Watch

Latest news

SpaceX Accelerates Employee Stock Vesting as IPO Approaches with Record Valuation Target

Sophia Claire|--

Israel-Lebanon Peace Talks: Historic Step Toward De-escalation, Yet Shadowed by Hezbollah's Absence

Sophia Claire|--

ECB's Interest Rate Path: Navigating Uncertainty Amidst Volatile Price Dynamics

Emma Rose|--

Latest Education Articles

How to Trade Natural Gas in 2026

How to Trade Natural Gas in 2026

Julian Parker|--
Gold or Silver CFDs? Key Differences Every CFD Trader Should Know

Gold or Silver CFDs? Key Differences Every CFD Trader Should Know

Julian Parker|--
Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Recommended Topics